Polyamines vascular smooth muscle acetate-salt hypertension study alteration vascular polyamine contents development deoxycorticosterone acetate-salt hypertension effects chronic administration alpha-difluoromethylornithine specific irreversible inhibitor ornithine decarboxylase polyamine biosynthesis vascular polyamine contents structure function development hypertension Control acetate-salt rats tap water drinking solution alpha-difluoromethylornithine weeks period blood pressures Vascular reactivity studies rings aorta tail artery Medial thickness vessel weight vascular polyamine contents arteries alpha-difluoromethylornithine treatment significant effect systolic blood pressure vascular structure function polyamine contents control animals elevation blood pressure increase medial thickness weight vascular polyamine contents vascular reactivity deoxycorticosterone acetate-salt rats alpha-difluoromethylornithine treatment results first vascular polyamine contents deoxycorticosterone acetate-salt rat chronic alpha-difluoromethylornithine treatment rise vascular polyamines elevation blood pressure attendant changes vasculature increase vascular polyamines critical link stimuli alterations vascular structure function pathogenesis deoxycorticosterone acetate-salt hypertension 